Avantor, Inc. (AVTR)
| Market Cap | 17.30B |
| Revenue (ttm) | 6.13B |
| Net Income (ttm) | 71.10M |
| Shares Out | 577.20M |
| EPS (ttm) | 0.12 |
| PE Ratio | 251.43 |
| Forward PE | 26.11 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 26 |
| Last Price | $29.92 |
| Previous Close | $30.69 |
| Change ($) | -0.77 |
| Change (%) | -2.51% |
| Day's Open | 30.75 |
| Day's Range | 29.74 - 30.84 |
| Day's Volume | 5,270,464 |
| 52-Week Range | 8.27 - 30.84 |
RADNOR, Pa., Jan. 21, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technolog...
RADNOR, Pa., Jan. 11, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced techno...
RADNOR, Pa., Jan. 11, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced techno...
The Covid-19 vaccine rally isn't just limited to biotech firms. Here are the top coronavirus stocks that are making mass vaccination possible.
As is the case every year, the major Wall Street firms we cover here at 24/7 Wall St.
How Avantor helps in the vaccine supply chain
Michael Stubblefield, Avantor CEO and president, describes his company's role in developing various vaccines to fight the coronavirus pandemic.
RADNOR, Pa., Dec. 17, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technolog...
Avantor CEO talks role in scaling up Covid-19 vaccine production
Avantor CEO Michael Stubblefield discussed how the biopharmaceutical supplier is helping to enable development of novel technologies.
These stocks have high upside that every investor should keep an eye on.
Avantor CEO on the mechanics of vaccine storage and distribution
Michael Stubblefield, Avantor CEO, joins "Squawk on the Street" to discuss the supply chain for coronavirus vaccine distribution.
Excited about the Covid-19 vaccines from Pfizer and Moderna? You'll be waiting a long time unless the vaccines can be shipped at 94 degrees below zero.
Avantor has had a stellar year, leveraging their diverse portfolio to retain recurring revenue over the 3rd quarter. Each segment of the portfolio remains exposed less than 3%, whilst allowing...
Avantor Wants to Bring Vaccine to Market in Record Time: CEO
Nov.18 -- Avantor President and Chief Executive Officer Michael Stubblefield discusses the company's role in the fight against the Covid-19 pandemic with Bloomberg's Vonnie Quinn on "Bloomberg...
In this article we'll take a closer look at the Top 10 Stocks Billionaire Daniel Loeb Just Bought. If you're impatient to see the pinnacle of the list, you can skip ahead to the Top 5 Stocks ...
In this article we are going to use hedge fund sentiment as a tool and determine whether Avantor, Inc. (NYSE:AVTR) is a good investment right now. We like to analyze hedge fund sentiment befor...
Avantor (AVTR) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
RADNOR, Pa., Nov. 5, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor" or the "Company"), a leading global provider of mission-critical products and services to customers in the life ...
RADNOR, Pa., Oct. 30, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor"), a leading global provider of mission-critical products and services to customers in the life sciences, advanc...
Avantor, Inc. (AVTR) CEO Michael Stubblefield on Q3 2020 Results - Earnings Call Transcript
These are the materials stocks with the best value, fastest growth, and most momentum for November.
RADNOR, Pa., Oct. 28, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor"), a leading global provider of mission-critical products and services to customers in the life sciences, advanc...
RADNOR, Pa., Oct. 27, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technolog...
Avantor (AVTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
RADNOR, Pa., Oct. 23, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technolog...
Company serves critical role in the development of a COVID-19 vaccine through its products and services RADNOR, Pa., Oct. 21, 2020 /PRNewswire/ -- Avantor Inc. (NYSE: AVTR), a leading global p...
RADNOR, Pa., Oct. 2, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technol...
RADNOR, Pa., Sept. 22, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technolo...
RADNOR, Pa., Sept. 1, 2020 /PRNewswire/ -- Avantor, Inc.
RADNOR, Pa., Aug. 31, 2020 /PRNewswire/ -- Avantor, Inc.
Avantor (AVTR) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
RADNOR, Pa., Aug. 19, 2020 /PRNewswire/ -- Avantor, Inc.
RADNOR, Pa., Aug. 10, 2020 /PRNewswire/ -- Avantor, Inc.
Avantor, Inc. (AVTR) CEO Michael Stubblefield on Q2 2020 Results - Earnings Call Transcript
The last week of July is also the week that marks the peak of the earnings season.
Avantor, Inc. (AVTR) delivered earnings and revenue surprises of 35.71% and -0.53%, respectively, for the quarter ended June 2020.
Shares of Avantor (NYSE:AVTR) rose 3.64% in after-market trading after the company reported Q2 results.
RADNOR, Pa., July 29, 2020 /PRNewswire/ -- Avantor, Inc.
Avantor (AVTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Avantor, Inc. (AVTR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.
RADNOR, Pa., July 21, 2020 /PRNewswire/ -- Avantor, Inc.
Avantor, Inc. (AVTR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
RADNOR, Pa., July 7, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor"), a leading global provider of mission critical products and services to customers in the life sciences and adva...
RADNOR, Pa., July 7, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technol...
RADNOR, Pa., July 7, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor"), a leading global provider of mission critical products and services to customers in the life sciences and adva...
RADNOR, Pa., June 30, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technolog...
Andreas Halvorsen (Trades, Portfolio)’s Viking Global Investors bought shares of the following stocks in both the fourth quarter of 2019 and the first quarter of 2020.
RADNOR, Pa., May 26, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor" or the "Company"), a leading global provider of mission critical products and services to customers in the life ...
Lee Ainslie (Trades, Portfolio)’s Maverick Capital bought shares of the following stocks in both the fourth quarter of 2019 and the first quarter of 2020.
Avantor (AVTR) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
RADNOR, Pa., May 22, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor" or the "Company"), a leading global provider of mission critical products and services to customers in the life ...
About AVTR
Avantor provides products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries worldwide. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, and clinical trial kits. It also provides equipment and instrument... [Read more...]
| Industry Specialty Chemicals | IPO Date May 17, 2019 |
| CEO Michael Stubblefield | Employees 12,000 |
| Stock Exchange NYSE | Ticker Symbol AVTR |
Analyst Forecasts
According to 20 analysts, the average rating for Avantor stock is "Strong Buy." The 12-month stock price forecast is 30.65, which is an increase of 2.44% from the latest price.